<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00905645</url>
  </required_header>
  <id_info>
    <org_study_id>G010193</org_study_id>
    <nct_id>NCT00905645</nct_id>
  </id_info>
  <brief_title>Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study</brief_title>
  <official_title>Sientra Sponsored Silimed Gel-Filled Mammary Implant Clinical Study Protocol: Core Clinical Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sientra, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sientra, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary
      augmentation, primary reconstruction, and/or revision of the female breast.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2002</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local complications</measure>
    <time_frame>10 Years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction determined by patients</measure>
    <time_frame>10 Years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1788</enrollment>
  <condition>Breast Augmentation</condition>
  <condition>Breast Reconstruction</condition>
  <condition>Breast Revision</condition>
  <arm_group>
    <arm_group_label>Primary Augmentation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Silimed Gel-Filled Mammary Implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary Reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Silimed Gel-Filled Mammary Implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Revison</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Silimed Gel-Filled Mammary Implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silimed Gel-Filled Mammary Implant</intervention_name>
    <arm_group_label>Primary Augmentation</arm_group_label>
    <arm_group_label>Primary Reconstruction</arm_group_label>
    <arm_group_label>Revison</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Subjects are admitted into the study only if all of the following eligibility is true:

          -  Female

          -  Age limitation specific to the indication:

               -  Primary Augmentation: Must be 18 years or older

               -  Primary Reconstruction: No age limit

               -  Revision: If original surgery was primary reconstruction, then no age limit. If
                  original surgery was primary augmentation, then must be 18 years or older.

          -  Adequate tissue available to cover implant(s)

          -  Willingness to follow study requirements (informed consent form, follow-up visits)

          -  Candidate for primary augmentation, primary reconstruction, or revision

        Exclusion Criteria

        Subjects are not eligible if any of the following criteria exist:

          -  Advanced fibrocystic disease, considered to be pre-malignant without mastectomy

          -  Inadequate or unsuitable tissue

          -  Active infection in the body at the time of surgery

          -  Pregnant or lactating

          -  Medical condition that might result in unduly high surgical risk and/or significant
             postoperative complications, in the judgment of the Investigator

          -  Use of drugs, including any drug that would interfere with blood clotting, that might
             result in high risk and/or significant postoperative complications

          -  Demonstrated psychological characteristics that are unrealistic or unreasonable given
             the risks involved with the surgical procedure

          -  Determination by physical examination that the subject does have any connective
             tissue/autoimmune disorder

          -  Existing carcinoma of the breast without accompanying mastectomy

          -  MRI scan is prohibited because of implanted metal device, claustrophobia, or other
             condition.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sientra, Inc.</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Stevens WG, Harrington J, Alizadeh K, Berger L, Broadway D, Hester TR, Kress D, dʼIncelli R, Kuhne J, Beckstrand M. Five-year follow-up data from the U.S. clinical trial for Sientra's U.S. Food and Drug Administration-approved Silimed® brand round and shaped implants with high-strength silicone gel. Plast Reconstr Surg. 2012 Nov;130(5):973-81. doi: 10.1097/PRS.0b013e31826b7d2f.</citation>
    <PMID>23096598</PMID>
  </reference>
  <reference>
    <citation>Stevens WG, Harrington J, Alizadeh K, Broadway D, Zeidler K, Godinez TB. Eight-year follow-up data from the U.S. clinical trial for Sientra's FDA-approved round and shaped implants with high-strength cohesive silicone gel. Aesthet Surg J. 2015 May;35 Suppl 1:S3-10. doi: 10.1093/asj/sjv020.</citation>
    <PMID>25948657</PMID>
  </reference>
  <reference>
    <citation>Stevens WG, Calobrace MB, Harrington J, Alizadeh K, Zeidler KR, d'Incelli RC. Nine-Year Core Study Data for Sientra's FDA-Approved Round and Shaped Implants with High-Strength Cohesive Silicone Gel. Aesthet Surg J. 2016 Apr;36(4):404-16. doi: 10.1093/asj/sjw015.</citation>
    <PMID>26961987</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2009</study_first_submitted>
  <study_first_submitted_qc>May 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2009</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Augmentation</keyword>
  <keyword>Breast Reconstruction</keyword>
  <keyword>Breast Revision</keyword>
  <keyword>Silicone breast implants</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

